Skip to main content
  • Saved

Commented on 's Post

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types

Source :

https://doi.org/10.3389/fonc.2021.558248

Despite encouraging results with immune checkpoint inhibition (ICI), a large fraction of cancer patients still does not achieve clinical benefit. Finding predictive markers in the complexity of the tumor microenvironment is a challenging task and often requires invasive procedures.

  • 3 weeks 4 days
    If this research is confirmed, this could have enormous clinical implications for initiating checkpoint inhibitors across a broad range of cancer patients